Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A very rare form of chronic hepatic porphyria characterized by bullous photodermatitis.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hepatoerythropoietic porphyria.
5 publications have been identified in PubMed for hepatoerythropoietic porphyria. Research spans Review / Meta-Analysis (60%) and Case Report / Case Series (40%).
Vu TN (2026). [PMID: 42213346](https://pubmed.ncbi.nlm.nih.gov/42213346/). *Am J Clin Dermatol*. [Review / Meta-Analysis]
Dotto PG (2025). [PMID: 40534320](https://pubmed.ncbi.nlm.nih.gov/40534320/). *Clin Genet*. [Case Report / Case Series]
Aarsand AK (2025). [PMID: 38940544](https://pubmed.ncbi.nlm.nih.gov/38940544/). *Liver Int*. [Review / Meta-Analysis]
Kaya Ç (2025). [PMID: 40051752](https://pubmed.ncbi.nlm.nih.gov/40051752/). *Eur J Case Rep Intern Med*. [Case Report / Case Series]
Balogun O (2024). [PMID: 38772406](https://pubmed.ncbi.nlm.nih.gov/38772406/). *Semin Liver Dis*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:50 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning hepatoerythropoietic porphyria
Updated Aug 8, 2026
A recent study published on PubMed details the clinical features and treatment effects of hepatoerythropoietic porphyria in a 2-year-old child. This research contributes to the understanding of this rare condition and its management.